Drugs and Devices

FDA approves new weight-loss drug

On July 17, the U.S. Food and Drug Administration (FDA) approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. Read More.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares